Evidence map›Paper›PMID 25161867›Full record

ArticleFEBS open bio2014

Short-term exposure of nontumorigenic human bronchial epithelial cells to carcinogenic chromium(VI) compromises their respiratory capacity and alters their bioenergetic signature.

Joana F Cerveira, María Sánchez-Aragó, Ana M Urbano, José M Cuezva

Abstract read
In one paragraph

Article in FEBS open bio, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Hexavalent chromium exposure impacts the metabolome of human lung fibroblast cells.Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Investigating the Role of Mitochondrial Respiratory Dysfunction during Hexavalent Chromium-Induced Lung Carcinogenesis.Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer · 2018
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Joana F CerveiraUnidade de Química-Física Molecular and Departamento de Ciências da Vida, Universidade de Coimbra, 3000-456 Coimbra, Portugal ; Centro de Biología Molecular "Severo Ochoa", CIBERER, Instituto de Investigación Hospital 12 de Octubre, Universidad Autónoma de Madrid, 28049 Madrid, Spain.
María Sánchez-AragóCentro de Biología Molecular "Severo Ochoa", CIBERER, Instituto de Investigación Hospital 12 de Octubre, Universidad Autónoma de Madrid, 28049 Madrid, Spain.
Ana M UrbanoUnidade de Química-Física Molecular and Departamento de Ciências da Vida, Universidade de Coimbra, 3000-456 Coimbra, Portugal ; Centro de Investigação em Meio Ambiente, Genética e Oncobiologia (CIMAGO), Universidade de Coimbra, 3004-504 Coimbra, Portugal.
José M CuezvaCentro de Biología Molecular "Severo Ochoa", CIBERER, Instituto de Investigación Hospital 12 de Octubre, Universidad Autónoma de Madrid, 28049 Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies on the impact of hexavalent chromium [Cr(VI)] on mammalian cell energetics revealed alterations suggestive of a shift to a more fermentative metabolism. Aiming at a more defined understanding of the metabolic effects of Cr(VI) and of their molecular basis, we assessed the impact of a mild Cr(VI) exposure on critical bioenergetic parameters (lactate production, oxygen consumption and intracellular ATP levels). Cells derived from normal human bronchial epithelium (BEAS-2B cell line), the main in vivo target of Cr(VI) carcinogenicity, were subjected for 48 h to 1 μM Cr(VI). We could confirm a shift to a more fermentative metabolism, resulting from the simultaneous inhibition of respiration and stimulation of glycolysis. This shift was accompanied by a decrease in the protein levels of the catalytic subunit (subunit β) of the mitochondrial H(+)-ATP synthase (β-F1-ATPase) and a concomitant marked increase in those of glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The corresponding alteration in the β-F1-ATPase/GAPDH protein ratio (viewed as a bioenergetic signature) upon Cr(VI) exposure was in agreement with the observed attenuation of cellular respiration and enhancement of glycolytic flux. Altogether, these results constitute a novel finding in terms of the molecular mechanisms of Cr(VI) effects.

Indexed as

2,4-DNP, 2,4-dinitrophenol2-DG, 2-deoxyglucoseAerobic glycolysisCellular bioenergetic indexCellular energy statusCellular respirationChromate lung cancerCr(III), trivalent chromiumCr(IV), tetravalent chromiumCr(VI), hexavalent chromiumCr(V), pentavalent chromiumDCF, 2′,7′-dichlorofluoresceinEDTA, ethylenediaminetetracetic acidETC, mitochondrial electron transport chainGAPDH, glyceraldehyde-3-phosphate dehydrogenaseIARC, International Agency for Research on CancerOCR, oxygen consumption rateOXPHOS, oxidative phosphorylationPBS, phosphate-buffered salinePI, propidium iodideROS, reactive oxygen speciesTCA, tricarboxylic acidWarburg effectβ-F1-ATPase, catalytic subunit (subunit β) of the mitochondrial H+-ATP synthase

Identifiers

PMID25161867
PMCPMC4141194

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.